Cargando…
Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis
Pharmacologic activation of stress-responsive signaling pathways provides a promising approach for ameliorating imbalances in proteostasis associated with diverse diseases. However, this approach has not been employed in vivo. Here we show, using a mouse model of myocardial ischemia/reperfusion, tha...
Autores principales: | Blackwood, Erik A., Azizi, Khalid, Thuerauf, Donna J., Paxman, Ryan J., Plate, Lars, Kelly, Jeffery W., Wiseman, R. Luke, Glembotski, Christopher C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331617/ https://www.ncbi.nlm.nih.gov/pubmed/30643122 http://dx.doi.org/10.1038/s41467-018-08129-2 |
Ejemplares similares
-
Pharmacologic ATF6 activating compounds are metabolically activated to selectively modify endoplasmic reticulum proteins
por: Paxman, Ryan, et al.
Publicado: (2018) -
Pharmacologic IRE1/XBP1s Activation Confers Targeted ER Proteostasis Reprogramming
por: Grandjean, Julia M.D., et al.
Publicado: (2020) -
ATF6 as a Nodal Regulator of Proteostasis in the Heart
por: Glembotski, Christopher C., et al.
Publicado: (2020) -
Designing Novel Therapies to Mend Broken Hearts: ATF6 and Cardiac Proteostasis
por: Blackwood, Erik A., et al.
Publicado: (2020) -
Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABA(A) receptors
por: Wang, Meng, et al.
Publicado: (2022)